INHCC Mission
The mission of the International NeuroHIV Cure Consortium (INHCC) is to provide cutting-edge investigation and expertise in central nervous system (CNS) aspects of HIV infection relevant to pathogenesis, treatment, and HIV remission, or 'cure.' Beginning with our first project in 2009 to evaluate the neurological implications of acute HIV infection, the group has grown to now encompass investigation into a broad array of early infection and cure strategy work. The consortium was established in 2014 to facilitate scientific exchange among investigators in a diverse array of fields and to leverage all aspects of the research portfolio through multidisciplinary studies during acute and chronic HIV infection and HIV remission studies.
|
INHCC News Welcome to the INHCC 2023 Summer Mentees as they join us June 5! Check out the bios coming in & those of mentees from previous years. What a CROI!! The INHCC was at CROI 2023 in Seattle. Several abstract presentations, meeting Dr Fauci, and great to see so many colleagues again! Check out the pics!
Dr Ferron reviewing poster by Drs Katie Holroyd, Phillip Chan etal at CRO 2023
|
MAJ McGuckin Wuertz of the MHRP mentors INHCC mentee, Eunice Chukwunyere in the lab!
Fireside Chat: INHCC Co-Director Serena Spudich & NIMH Director Joshua Gordon
|
Consortium Leadership
Serena Spudich MD, MA
Yale University
Lydie Trautmann, EngD, PhD
US Military HIV Research Program (MHRP)
INHCC work is sponsored by NIH, NIMH, NINDS, NIAID, the Henry Jackson Foundation (HJF) and the Walter Reed Army Institute of Research (WRAIR)
